BridgeMD
New treatment option for Small Bowel Bleeding
Official title Early Videocapsule Endoscopy for Upper Gastrointestinal Bleeding
ClinicalTrials.gov ID: NCT05108844
What this study is testing
- What it's testing
- The objective of this study is to determine whether early video capsule endoscopy (VCE) immediately after a negative gastroscopy in the setting of suspected upper gastrointestinal bleeding (UGIB) improves patient outcomes as compared to the standard approach which typically involves performing colonoscopy prior to small bowel investigations. We aim to examine the differences in diagnostic yield, total number of procedures, length of hospitalization, mortality rates, and healthcare cost between the two groups.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- Age ≥ 18 years
- New onset of acute gastrointestinal bleeding defined as:
- The presence of melena/maroon stool on physical exam OR history of melena/maroon stool within 48 hours of emergency room presentation PLUS
- Hemoglobin drop of ≥ 20 g/L from patient's baseline
- Have capacity to consent
You likely can't join if
- Inability to provide consent due to lack of capacity, language barrier or other reasons
- Pregnant women
- Prior history of small bowel surgery
- Prior history of Crohn's disease
- Prior history of small bowel or colonic strictures
- Prior history of abdominal radiation
See the full eligibility criteria
- Age ≥ 18 years
- New onset of acute gastrointestinal bleeding defined as:
- The presence of melena/maroon stool on physical exam OR history of melena/maroon stool within 48 hours of emergency room presentation PLUS
- Hemoglobin drop of ≥ 20 g/L from patient's baseline
- Have capacity to consent
- Hemodynamically stable (i.e. blood pressure \>100/60 or pulse \<110 at the time of consent)
- Initial gastroscopy negative for active bleeding or potential bleeding source
- Inability to provide consent due to lack of capacity, language barrier or other reasons
- Pregnant women
- Prior history of small bowel surgery
- Prior history of Crohn's disease
- Prior history of small bowel or colonic strictures
- Prior history of abdominal radiation
The study team makes the final eligibility decision.
Where it's taking place
- Edmonton, Alberta, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Edmonton, Alberta, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.